Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis

Arthritis and Rheumatism

Volumn 58, Issue 11, 2008, Pages 3609-3617

  Codolo, Gaia ^a   Amedei, Amedeo ^b   Steere, Allen C ^c   Papinutto, Elena ^a   Cappon, Andrea ^a   Polenghi, Alessandra ^a   Benagiano, Marisa ^b   Paccani, Silvia Rossi ^d   Sambri, Vittorio ^e   Del Prete, Gianfranco ^b   Baldari, Cosima Tatiana ^d   Zanotti, Giuseppe ^a   Montecucco, Cesare ^f   D'Elios, Mario Milco ^b   De Bernard, Marina ^a  

^a VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF SIENA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; NEUTROPHIL ACTIVATING PROTEIN A; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL IMMUNITY; BORRELIA BURGDORFERI; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HUMAN; INNATE IMMUNITY; LYME DISEASE; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SYNOVIAL FLUID;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; CHEMOKINES, CXC; CHILD; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-6; LYME DISEASE; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHILS; SYNOVIAL FLUID; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 55849118788     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.23972     Document Type: Article

References (48)

1. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease: a tick-borne spirochetosis? Science 1982; 216:1317-9.
2. Jaenson TG. The epidemiology of Lyme borreliosis. Parasitol Today 1991;7:39-45.
3. Steere AC. Lyme disease. N Engl J Med 2001;345:115-25.
4. Wilske B. Diagnosis of Lyme borreliosis in Europe. Vector Borne Zoonotic Dis 2003;3:215-27.
5. Mullegger RR. Dermatological manifestations of Lyme borreliosis. Eur J Dermatol 2004;14:296-309.
6. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725-31.
7. Georgilis K, Noring R, Steere AC, Klempner MS. Neutrophil chemotactic factors in synovial fluids of patients with Lyme disease. Arthritis Rheum 1991;34:770-5.
8. Yssel H, Shanafelt MC, Soderberg C, Schneider PV, Anzola J, Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 1991;174:593-601.
9. Lim LC, England DM, Glowacki NJ, DuChateau BK, Schell RF. Involvement of CD4+- T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters. Infect Immun 1995;63:4818-25.
10. McKisic MD, Redmond WL, Barthold SW. T cell-mediated pathology in murine Lyme borreliosis. J Immunol 2000;164: 6096-9.
11. Brown CR, Reiner SL. Experimental Lyme arthritis in the absence of interleukin-4 or γ interferon. Infect Immun 1999;67:3329-33.
12. Christopherson JA, Munson EL, England DM, Croke CL, Remington MC, Molitor ML, et al. Destructive arthritis in vaccinated interferon γ-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor α. Clin Diagn Lab Immunol 2003;10:44-52.
13. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007;19:281-6.
14. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006;203:1685-91.
15. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-50.
16. Iwakura Y, Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116:1218-22.
17. Chabaud M, Garnero P, Dayer JM, Guerne PA, Fossiez F, Miossec P. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 2000;12:1092-9.
18. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999;103:1345-52.
19. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000;165:6107-15.
20. Burchill MA., Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, et al. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun 2003;71:3437-42.
21. D'Elios MM, Amedei A, Cappon A, Del Prete G, de Bernard M. The neutrophil-activating protein of Helicobacter pylori (HPNAP) as an immune modulating agent. FEMS Immunol Med Microbiol 2007;50:157-64.
22. Tonello F, Dundon WG, Satin B, Molinari M, Tognon G, Grandi G, et al. The Helicobacter pylori neutrophil-activating protein, an iron-binding protein with dodecameric structure. Mol Microbiol 1999;34:238-46.
23. Montecucco C, de Bernard M. Molecular and cellular mechanism of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect 2003;5:715-21.
24. Zanotti G, Papinutto E, Dundon WG, Battistutta R, Seveso M, Del Giudice G, et al. Structure of the neutrophil-activating protein from Helicobacter pylori. J Mol Biol 2002;323:125-30.
25. Satin B, Del Giudice G, Della Bianca V, Dusi S, Laudanna C, Tonello F, et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 2000;191:1467-76.
26. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997;390:580-6.
27. Li X, Pal U, Ramamoorthi N, Liu X, Desrosiers DC, Eggers CH, et al. The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol Microbiol 2007;63:694-710.
28. Marangoni A, Aldini R, Sambri V, Giacani L, Di Leo K, Cevenini R. Production of tumor necrosis factor α by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. FEMS Immunol Med Microbiol 2004;40:187-91.
29. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Recomm Rep 1990;39:1-43.
30. Vaz A, Glickstein L, Field JA, McHugh G, Sikand VK, Damle N, et al. Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease. Infect Immun 2001;69:7437-44.
31. Centers for Disease Control (CDC). Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995;44:590-1.
32. Kannian P, McHugh G, Johnson BJ, Bacon RM, Glickstein LJ, Steere AC. Antibody responses to Borrelia burgdorferi in patients with antibiotic- refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum 2007;56:4216-25.
33. Boncristiano M, Rossi Paccani S, Barone S, Ulivieri C, Patrussi L, Ilver D, et al. The Helicobacter pylori vacuolating toxin inhibits T-cell activation by two independent mechanisms. J Exp Med 2003;198:1887-97.
34. Amedei A, Cappon A, Codolo G, Cabrelle A, Polenghi A, Benagiano M, et al. The neutrophil activating protein of Helicobacter pylori promotes Th1 immune responses. J Clin Invest 2006;116:1092-101.
35. Knauer J, Siegemund S, Muller U, Al-Robaiy S, Kastelein RA, Alber G, et al. Borrelia burgdorferi potently activates bone marrow-derived conventional dendritic cells for production of IL-23 required for IL-17 release by T cells. FEMS Immunol Med Microbiol 2007;49:353-63.
36. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715-25.
37. Haupl T, Landgraf S, Netusil P, Biller N, Capiau C, Desmons P, et al. Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines. FEMS Immunol Med Microbiol 1997;1:15-23.
38. Shanafelt MC, Hindersson P, Soderberg C, Mensi N, Turck CW, Webb D, et al. T cell and antibody reactivity with the Borrelia burgdorferi 60-kDa heat shock protein in Lyme arthritis. J Immunol 1991;146:3985-92.
39. Akin E, McHugh GL, Flavell RA, Fikrig E, Steere AC. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun 1999;67:173-81.
40. Liang FT, Alvarez AL, Gu Y, Nowling JM, Ramamoorthy R, Philipp MT. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi. J Immunol 1999;163:5566-73.
41. Ma B, Christen B, Leung D, Vigo-Pelfrey C. Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J Clin Microbiol 1992;30:370-6.
42. Steere AC, Glickstein L. Elucidation of Lyme arthritis. Nat Rev Immunol 2004;4:143-52.
43. Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, et al. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998;281:703-6.
44. Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med 2000;191:1233-40.
45. Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 2003;100:5986-90.
46. Shen F, Ruddy MJ, Plamondon P, Gaffen SL. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-α-induced genes in bone cells. J Leukoc Biol 2005;77:388-99.
47. Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Di Padova FE, et al. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 2005;167:141-9.
48. Lawson JP, Steere AC. Lyme arthritis: radiologic findings. Radiology 1985;154:37-43.